CHMP Recommends Approval of Galderma's Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
Nemolizumab is a first-in-class monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31. 2 IL-31 is a neuroimmune cytokine that drives itch and is ...
Condé Nast Traveler on MSN12h
63 Gift Ideas for Women Who Travel
Our favorite women travelers share the Moroccan lip stain, Greek mountain tea, and Parisian chocolates on their wish list.